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Summary Ingestion of diets containing corn oil or marine fish oils is known to increase or decrease,
respectively, the growth of transplantable rodent tumours. The active agents in these oils have been identified
as linoleic acid (in corn oil) and omega-3 fatty acids (in marine oils), but it is still not known how they
influence the tumour growth processes. In these experiments we examined the effects of plasma free omega-6
and omega-3 fatty acids on the rate of 3H-thymidine incorporation in tissue-isolated hepatoma 7288CTC
perfused in situ. Host Buffalo rats were fed an essential fatty acid-deficient diet. Plasma and tumours in these
animals contained low endogenous levels of both omega-6 and omega-3 fatty acids. Perfusion of these tumours
for 2 h with donor whole blood containing added omega-6 free fatty acids, including 0.5 mM linoleic
(C18:2,N-6), gamma-linolenic (C18:3,N-6), dihomo-gamma-linolenic (C20:3,N-6) or arachidonic acids (C20:
4,N-6), increased the rate of 3H-thymidine incorporation. Linoleic acid was about three times more effective
than the other omega-6 fatty acids. Typical hyperbolic substrate-saturation curves were observed as the plasma
free linoleate or arachidonate concentration was increased. When perfused alone plasma free omega-3 fatty
acids had no effect on tumour 3H-thymidine incorporation, but in the presence of linoleic acid the omega-3
fatty acids, alpha-linolenic (C18:3,N-3) and eicosapentaenoic (C20:5,N-3), competitively inhibited both
tumour linoleate uptake and the stimulative effect on 3H-thymidine incorporation. The results suggest that the
ambient plasma free linoleic and arachidonic acid concentrations in host arterial blood directly influence the
rate of tumour DNA synthesis. Plasma free omega-3 fatty acids appear to modulate the effect of linoleic acid
by competitively inhibiting its uptake. These relationships could explain the actions of dietary linoleic and
omega-3 fatty acids on tumour growth in vivo.
Dietary fats plays an important role in tumour growth in
rodents. High fat diets containing corn, soybean or safflower
oils decrease the latent period between implantation and
tumour appearance (Rogers & Wetsel, 1981; Abraham &
Hillyard, 1983) and increase the rate of growth ofestablished
tumours (Rogers & Wetsel, 1981; Gabor et al., 1985). The
search for the substance responsible for the growth-stimula-
tive effect has focused on linoleic acid (C18:2,N-6), an essen-
tial fatty acid that constitutes 55 to 80% of the fatty acid
content of these oils. Feeding mice a fat-free diet sup-
plemented with as little as 0.1% purified linoleic acid in-
creased growth of a transplantable mammary tumour as
much as a diet containing 15% corn oil (Hillyard & Abra-
ham, 1979). Surprisingly, a fat-free diet supplemented with
arachidonic acid (C20:4,N-6) alone had no significant effect
on tumour growth (Hillyard & Abraham, 1979; Hillyard et
al., 1980). Measurements of tumour growth in groups of rats
fed diets containing different amounts of corn oil showed
increased growth as the linoleic acid content was increased; a
plateau was reached at about 3 to 4% corn oil (Ip et al.,
1985) suggesting that the effect of linoleate was saturable.
Dietary fish oils, on the other hand, have effects opposite
from those of corn oil. Ingestion of fish oils increased the
length of the latent period between implantation and detec-
tion of a palpable tumour (Jurkowski & Cave, 1985) and
slowed the growth rate of established tumours (Karmali et
al., 1984; Gabor & Abraham, 1986). Addition of fish oils or
individual omega-3 fatty acids to diets containing linoleic
acid inhibited the stimulative effect of the linoleate on
tumour growth (Gabor & Abraham, 1986).
In previous experiments, using tissue-isolated hepatomas
7288CTC perfused in situ, we identified plasma free linoleic
and arachidonic acids as the active agents in hyperlipemic
blood responsible for a stimulative effect on tumour 3H-
thymidine incorporation (Sauer & Dauchy, 1988). Subse-
quently, we showed that the uptake of these free fatty acids
by hepatoma 7288CTC in vivo was dependent on the rate of
supply to the tumour (Sauer & Dauchy, 1992). In this study
we have used tissue-isolated tumours perfused in situ to
examine the effects of purified omega-6 and/or omega-3 fatty
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acids on the incorporation of 3H-thymidine into tumour
DNA.
Materials and methods
Reagents
Linoleic, arachidonic, gamma-linolenic (C18:3,N-6) dihomo-
gamma-linolenic (C20:3,N-6), alpha-linolenic (C18:3,N-3),
octadecatetraenoic (C18:4,N-3), eicosapentaenoic (C20:5,N-
3) and docosahexaenoic acids (C22:6,N-3) were purchased
from Sigma Chemical Co., St. Louis, MO. The purity of
these fatty acids was measured by gas chromatography and
was greater than 98%, in agreement with the specifications of
the supplier. Heptane (HPLC grade), chloroform, methanol
and ethanol were obtained from Fisher Chemical Co. The
heptane and chloroform were redistilled before use. Methyl
esters of rapeseed oil fatty acids and other standard free fatty
acids were purchased from Supelco, Bellefonte, PA. [Methyl-
3H]Thymidine (6.7 Ci mmol-1) was a product of Research
Products International, Mt. Prospect, IL. [1-_4C]Linoleic acid
(50mCimmol-1) was purchased from NEN Research Prod-
ucts, Boston, MA.
Animals and diets
The male and female Buffalo rats used in these experiments
were obtained from colonies established here. All animals
had free access to food and water and were maintained at
23'C in a room with lights from 0600 to 1800 h. Breeding
pairs, and pregnant and nursing mothers were fed a standard
laboratory chow (Prolab mouse, rat and hamster 1000 for-
mula; Agway, Inc., Syracuse, NY). Lipid analyses showed
that this diet contained 39.2 mg fatty acid g-' diet of which
21.2% was linoleic acid (Sauer & Dauchy, 1992).
Young male and female rats, weighing 30 to 45 g, were
separated from their mothers at 21 days of age and were fed
ad libitum an essential fatty acid (EFA)-deficient ration
(AIN-76 semipurified diet containing 5% fat as U.S.P. stearic
acid, catalog No. 960240, ICN Biochemical, Cleveland, OH).
The manufacturer's specifications indicated that this diet con-
tained 50% sucrose, 15% corn starch, 20% casein, 0.3%
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DL-methionine, 0.2% choline bitartrate, 5% USP stearic
acid, 3.5% mineral mix and 1% vitamine mix. Lipid analysis
(performed in this laboratory) showed that it contained
several long and short chain fatty acids; however, linoleic and
arachidonic acids were undetectable. Weanling rats fed this
diet had a rapid decrease in plasma free linoleic and arac-
hidonic acid concentrations and an increase of a new fatty
acid, tentatively identified and assumed to be the triene,
eicosa-5,8,11-trienoic acid, that is formed during EFA-
deficiency (Holman, 1960). After 8 to 12 weeks on this diet
the rats ate about 20-25 g day 1, weighed 225-300 g and
were suitable for tumour implantation and as sources of
EFA-deficient donor blood. Total plasma free fatty acid
concentrations in these animals were 0.63 ± 0.24 mM
(mean ± s.d., n = 25). Mean concentrations of the six most
abundant free fatty acids were: C14:0, 0.01 ± 0.01 mM;
C16:0, 0.20 ± 0.08 mM; C16:1, 0.10 ± 0.05 mM; C18:0,
0.04 0.01 mM; C18:1, 0.24 ± 0.11 mM; and C20:3 (n9),
0.03 ± 0.01 mM. Linoleic acid was undetectable and
arachidonic acid was 0.01 ± 0.01 mM. A C20:3(N-9)/
C20:4(N-6) ratio of greater than 0.4 is indicative of EFA-
deficiency (Holman, 1960).
Tumour implantation andperfusion
All experiments were performed with Morris hepatoma 7288
CTC grown subcutaneously as tissue-isolated tumours (Sauer
et al., 1982). The procedures for implantation of tissue-
isolated tumours were as described (Sauer & Dauchy, 1992).
Tumour growth rates were decreased in EFA-deficient rats
and a palpable tumour mass was not evident until after a
latent period of about 12 days. Growing tumours were used
for perfusion when the weight, estimated by measurements
made through the skin (Sauer et al., 1986), was 5 to 6 g.
Tissue-isolated hepatomas 7288CTC were perfused for 2 h
as described (Sauer & Dauchy, 1988; 1992). Initial experi-
ments showed that steady state rates of tumour uptake of
exogenous linoleic acid were established within 15 min after
the start of the perfusion. Arterial blood samples for analysis
were collected from a Y-tube placed in the arterial blood
perfusion line immediately before the tumour and venous
samples were collected from the butterfly catheter draining
the tumour vein. Rates of tumour fatty acid supply and
uptake were calculated as described (Sauer & Dauchy, 1992).
Both rates have units of ig or nmol min ' g'l tumour.
Twenty min before the end of the perfusion the tumour was
labelled with [methyl-3H]thymidine (2 yCi g- estimated tu-
mour weight, in saline) injected directly into the arterial
blood catheter (Sauer & Dauchy, 1988). The 3H-thymidine
made one pass through the tumour; unincorporated thymi-
dine appeared in the tumour venous blood 2 min after injec-
tion, reached a peak at 3 to 4 min and was nearly completely
eliminated from the tumour in 20 min (data not shown). The
tumour was rapidly removed from the animal, weighed, and
frozen until analysis. A 20% homogenate was made from the
thawed tissue in 0.9% saline solution. Tumour DNA content
and the 3H-thymidine incorporation into tumour DNA were
measured as described (Sauer & Dauchy, 1988).
Collection andpreparation ofdonor blood
Eighty to 90 ml of whole blood were collected from 10
heparinised adult, EFA-deficient rats and filtered through
two layers of cheesecloth. These whole blood preparations
were used in the perfusion experiments to determine the
control rates of 3H-thymidine incorporation in the absence of
EFAs (the baseline rate of 3H-thymidine incorporation).
Identical pooled whole blood samples collected from donor
EFA-deficient rats were used in other experiments to deter-
mine the effects of single fatty acids or mixtures of fatty
acids. To perform these experiments the donor EFA-deficient
blood was supplemented with exogenous fatty acid(s), as
follows: the whole blood preparations were separated into
cells and plasma by centrifugation. One or two solid, purified
fatty acids (as sodium salts) were added to the plasma frac-
tion and dissolved by warming to 10-15°C with gentle mix-
ing. An amount of the cellular fraction was added back to
the plasma to give a reconstituted whole blood mixture with
a hematocrit of 50%. For most experiments the concentra-
tions of the exogenous free fatty acids are given as plasma
concentrations (mM), since these were analysed directly.
Because the plasma was diluted 1:1 by cells, the free fatty
acid concentration in the whole blood perfusate was one-half
the plasma concentration.
To determine that the exogenous free fatty acid remained
as a free fatty acid and was bound to albumin, we deter-
mined the molar ratios for free fatty acid/albumin in EFA-
deficient plasma samples (and isolated albumin and globulin
fractions) and in plasma samples supplemented with linoleic
acid. Heparinised blood (45 ml), collected from 5 EFA-
deficient donor rats, was centrifuged to obtain a pooled
plasma fraction (21 ml). The plasma was dialysed for 48 h in
the cold against phosphate-buffered (5 mM) saline, pH 7.4,
and divided into two 10ml portions. One portion was unt-
reated and 1.4 mg sodium linoleate was dissolved in the
other. The treated and untreated plasma samples were sep-
arated into albumin and globulin fractions by chromato-
graphy on Affigel blue (Travis & Pannel, 1973). Samples of
the EFA-deficient and linoleate-treated plasmas and the
albumin and globulin fractions isolated from them were
analysed for free fatty acids and albumin (Doumas & Biggs,
1972). The albumin concentration in the plasma samples was
0.36 mM. The free fatty acid/albumin molar ratios in un-
treated and sodium linoleate-treated, EFA-deficient plasmas
were 2.2 and 4.1, respectively. Similar molar rations were
observed in the isolated albumin samples indicating that the
added linoleic acid was recovered bound to albumin. Glob-
ulin fractions were free of albumin and contained no detec-
table free fatty acids.
Analysis of the free linoleic acid content in treated and
untreated plasma samples and separation of the plasma lipids
by thin-layer chromatography (Sauer & Dauchy, 1992) show-
ed that all of the exogenous fatty acid was recovered in the
free fatty acid fraction. No evidence for redistribution of
exogenous free fatty acid to another plasma lipid class was
found in the perfusate. Also, no redistribution of the exog-
enous free fatty acid was found in plasma of venous blood
collected after it had passed through the tumour indicating
that the exogenous free fatty acid not taken up by the
tumour remained bound to albumin and was not transferred
by the tumour to another plasma lipid class.
In some experiments [1-_4C]linoleic acid was added to the
donor plasma in addition to exogenous unlabeled linoleic
acid, as described (Sauer & Dauchy, 1992). After reconstitu-
tion of the whole blood following addition of the cellular
fraction, these donor blood preparations were used to deter-
mine linoleic acid uptake and utilisation during the perfusion.
Analysis offatty acids
Free fatty acids in plasma, isolated albumin or globulin
fractions were extracted and prepared for analysis as des-
cribed (Sauer & Dauchy, 1988, 1992). Measurements were
made using either a Perkin-Elmer Sigma 3 gas chromato-
graph equipped with a 3.2 mm x 1.8 m 5% diethylene glycol
succinate column at 200°C (nitrogen as carrier gas) and
electronic integrator (Model 3390A; Hewlett-Packard, Sun-
nyvale, CA) or a Hewlett-Packard Model 5280A gas chroma-
tograph equipped with a 0.25 mm x 30 m capillary column
(Model 2330, Supelco Inc., Bellefonte, PA) at 190°C (helium
as carrier gas, split, 100:1) an electronic integrator (Model
3396A, Hewlett-Packard) and an autoinjector (Model 7673A,
Hewlett-Packard). Injection port and flame ionisation detec-
tor were at 220°C. Fatty acid methyl esters were identified by
their retention times compared to known standards.
Statisticalanalysis
Means are presented ± s.d., as indicated, and were compared
by one-way analysis of variance (ANOVA) and the Duncan
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Results
Uptake of[J-4C]linoleic acid by hepatoma 7288CTCperfused
in situ
Table I shows the results of experiments in which two
hepatomas 7288CTC were perfused in situ with donor blood
from EFA-deficient rats that contained two different concent-
rations of '4C-linoleic acid. Uptakes of linoleic acid mass and
radioactivity were identical for the two tumours; except for
the first time points, the specific activities of '4C-linoleic acid
in the arterial blood perfusate and the tumour venous blood
effluent were nearly identical. Also, the rates of linoleic acid
supply and uptake were reasonably constant during the 1 and
2 h of perfusion. '4CO2 was released into the tumour venous
blood indicating that the '4C-linoleic acid removed from the
arterial blood was utilised. The rates of oxidation of 14C-
linoleate in experiments 1 and 2 gradually increased through-
out the perfusion. After 60 and 120 min of perfusion, the
'4C02 production rates by the 2 hepatomas were about 2 and
3.5% of the total 14C-linoleic acid uptake, respectively, values
that are similar to those observed during '4C-palmitic acid
uptake and oxidation in hepatoma 7288CTC perfused in situ
(Sauer & Dauchy, 1992).
Supply and uptake rates for radioactivity (d.p.m. min-'
g-' tumour) are not shown in Table I. However, these rates
may be calculated by multiplying the rate of '4C-linoleic acid
uptake (fg min-' g- ) by the specific activity (d.p.m. Lgg 1) in
the blood sample. The total tumour '4C-linoleic acid uptake
during the 1 h perfusion in experiment 1 was estimated to be
74.4 1g g-' and 49,980 d.p.m. g' tumour. Total tumour
linoleic acid content at the time of harvest was 922fLgg-'
and contained 64,620 d.p.m. g-1; thus, the '4C-content found
in the tumour was 130% of the estimated total uptake. In
experiment 2, in which the perfusion was for 120min, linoleic
acid uptake was estimated to be 276 gg-' and 125680
d.p.m. g '. Total tumour linoleic acid content was 721 jig g-'
and contained 122880 d.p.m. g-'; therefore, in experiment 2
the '4C-content at time of tumour harvest was 98% of the
expected uptake.
Comparison ofomega-6 and omega-3fatty acids
Several exogenous omega-6 and omega-3 free fatty acids,
adjusted to plasma concentrations of about 0.5 mM in the
arterial blood perfusate, were perfused through tissue-isolated
hepatomas 7288CTC to test for their ability to affect tumour
3H-thymidine incorporation. As shown in Table II, clear
differences were noted. Each of the four omega-6 fatty acids
increased the amount of tumour 3H-thymidine incorporation
about 2 to 3.5 times above the mean baseline value observed
when untreated EFA-deficient donor blood was the per-
fusate. Linoleic acid was the most effective omega-6 free fatty
acid; gamma-linolenic, dihomo-gamma-linolenic and arachi-
donic acids had about one-third the effect of linoleate.
Neither of the four omega-3 fatty acids affected tumour
3H-thymidine incorporation.
Dose-response relationships
Since linoleic and arachidonic acids are the most abundant
free omega-6 fatty acids in the arterial blood of rats fed a
normal diet and both are taken up by hepatoma 7288CTC in
proportion to the rate of supply (Sauer & Dauchy, 1992), we
investigated the effect of different concentrations of these
fatty acids on tumour 3H-thymidine incorporation. These
data are shown in Figure la. The initial plasma concentra-
tion used (0.09 mM) had no effect; however, perfusion of
tumours with increased concentrations of both fatty acids
increased tumour 3H-thymidine incorporation. Hyperbolic-
shaped dose-response curves were observed. The Vmax rate of
incorporation observed with linoleic acid was about 3 to 3.5
times greater than that for arachidonic acid, indicating that
the difference between these two fatty acids noted in Table II
was not simply a concentration effect, but rather, that mole
for mole linoleic acid was more effective than arachidonic
acid. Despite the higher rate of 3H-thymidine incorporation,
tumour DNA content was unchanged during perfusion for
2 h with blood containing either linoleic or arachidonic acids.
DNA content of control tumours perfused for 2 h with blood
from EFA-deficient donor rats was 2.76 ± 0.07 mg g-'
tumour. After 2 h ofperfusion with blood supplemented with
0.7 mM linoleic acid or 0.93 mM arachidonic acid, the tumour
DNA contents were 2.97 ± 0.09 and 2.76 ± 0.11 mg g-'
tumour, respectively. Mean DNA content of all tumours was
2.84 ± 0.08 mg g-' tumour (n = 54). Figure lb shows the
relationships between linoleic acid supply and uptake for the
tumours perfused in the experiments shown in Figure la.
Uptake of linoleic acid by hepatomas 7288CTC perfused in
situ showed the same direct dependency on supply that was
Table I Supply and uptake of arterial blood free [1-'4C]-linoleic acid in hepatoma 7288CTC perfused in situ
[1- 4C]-Linoleic acid
Specific 14C02 Perfusion Content Content activity Supply Uptake Content Release
time Tissue fgml- d.p.m. ml-' d.p.m.dg' lAgmin-'g- ltg min-'g- d.p.m. ml-' dp.m. ming-
Experiment 1
15 min A 107 58900 550 2.28 142
V 38 28590 758 1.52 223 2 30 min A 98 63570 650 2.09 139
V 46 29860 648 1.17 522 8 45 min A 95 59510 641 2.03 140
V 53 30410 581 0.97 802 13 60 min A 107 62650 587 2.28 121
V 50 33230 671 1.28 867 15
T 922a 64620b 70c
Experiment 2
30 min A 178 75710 425 4.07 0
V 67 35200 525 2.65 750 16 60 min A 165 79140 479 4.04 176
V 72 35520 521 2.51 1450 27 120 min A 148 80690 545 3.63 185
V 76 45340 597 2.02 1813 35
T 72la 122880b 170c
Experiments I and 2: A = arterial blood; V = tumour venous blood; T = tumour; aSlg g- I; blAd.p.m. g I; and cassumes that all radioactivity in the tumour was 14C-linoneic acid. In experiment 1: total tumour '4C-linoleate uptake was 49980 d.p.m. g-'; tumour weight was 6.23 g; arterial and venous blood flow were 0.133 and 0.124mlmin-', respectively; and the linoleate concentration in arterial blood was 0.36mm. In experiment 2: total tumour '4C-linoleate uptake was 125,680 d.p.m. g '; tumour weight was 6.12 g; arterial and venous blood flow were 0.15 and 0.13mlmin-'; and the linoleate concentration in arterial blood was 0.58mm.300 L.A. SAUER & R.T. DAUCHY
Table II Effects of omega-6 and omega-3 fatty acids on 3H-thymidine incorporation in
hepatoma 7288CTC perfused in situ
Tumour
Plasma Tumour fatty 3H-thymidine
concentration acid uptake incorporation
Fatty acid added mm nmolg-'min-' d.p.m. l.g- DNA
None 44 6
Linoleic acid 0.50 10.8 ± 0.9 342 ± 8b,c
(18:2n6)
y-Linolenic acid 0.52 3.7 ± 1.0 147 ± 15b
(18:3n6)
Dihomo-y-Linolenic acid 0.67 8.1 ± 0.8 145 ± gb
(20:3n6)
Arachidonic acid 0.46 2.9 ± 0.6 122 ± 12b
(20:4n6)
a-Linolenic acid 0.71 1.9 ± 1.0 45 ± 5a
(18:3n3)
Octadecatetraenoic acid 0.56 1.6 ± 0.6 40 ± 4a
(18:4n3)
Eicosapentaenoic acid 0.43 2.4 ± 0.9 50± 3a
(20:5n3)
Docosahexaenoic acid 0.54 1.6 ± 0.4 43 ± 3a
(22:6n3)
aThese values are not different (P >0.05) from values obtained in the absence of
added fatty acid. bThese values are different (P <0.01) from values obtained in the
absence of added fatty acid or in the presence of the omega-3 fatty acids. cValues for
linoleic acid are different (P <0.01) from those for other omega-6 fatty acids.
Tissue-isolated tumours weighing 5-6 g were perfused for 2 h in situ with whole blood
collected from essential fatty acid-deficient rats. Exogenous fatty acid was added, as
indicated. Values are means ± SD for three experiments.
a
observed in in vivo tumours growing in EFA-sufficient rats
(Sauer & Dauchy, 1992). Most importantly, the uptake of
linoleate was dependent on supply throughout the plasma
concentrations examined. Therefore, the stimulative effect of
plasma free linoleic acid on tumour 3H-thymidine incorpora-
tion reached a plateau while the rate of linoleic acid uptake
was still increasing; the linoleic acid dependent reaction was
saturated.
0 2 4 6 8 10 12
Supply, nmol min-1 g-1
Figure la The relationship between the arterial plasma linoleic
or arachidonic acid concentration and 3H-thymidine incorpora-
tion into hepatoma 7288CTC DNA; (0) linoleic acid; (0)
arachidonic acid. Each point represents the mean ± s.d. for per-
fusions performed on three different tumours. b, The relationship
between the supply and uptake of free linoleic acid by hepatoma
7288CTC. These data are from the same perfusions shown in a.
Results of the regression analysis were: slope = 0.696, inter-
cept = 0.048, and correlation coefficient = 0.9496.
Competition among omega-6, omega-9 and omega-3fatty acids
Interactions among oleic, arachidonic, alpha-linolenic or eic-
osapentaenoic acid and linoleic acid were examined by com-
bining the free fatty acids in the arterial blood perfusate and
measuring the 3H-thymidine incorporation in tumours per-
fused with the mixtures. As shown in Table III, oleic acid, at
a high plasma concentration, did not alter the stimulative
effect of linoleic acid. (We have previously shown that
saturated fatty acids or oleic acid had no effect on tumour
3H-thymidine incorporation when added alone (Sauer &
Dauchy, 1988)). The response due to arachidonic acid ap-
peared to be additive to that of linoleate and both alpha-
linolenic and eicosapentaenoic acids (at concentrations about
equal to that of linoleate) inhibited linoleic acid uptake and
the stimulative effect on 3H-thymidine incorporation by
about two-thirds.
The inhibitory effect of these omega-3 fatty acids was
examined further by perfusing individual tumours with art-
erial whole blood containing a fixed plasma concentration of
linoleic acid (0.5 mM) and different plasma concentrations of
either alpha-linolenic or eicosapentaenoic acid that ranged
from 0 to about 0.9 mM (Figures 2a and b). Increasing
concentrations of these omega-3 fatty acids inhibited both
tumour linoleic acid uptake and the positive effect of
linoleate on 3H-thymidine incorporation. Dixon plots of these
data (shown in the insets) indicate that the inhibitory effect
of alpha-linolenic and eicosapentaenoic acids on both func-
tions was competitive. Ki values for alpha-linolenic acid were
0.18 mm for the inhibition of linoleate uptake and 0.25 mM
for the inhibition of 3H-thymidine incorporation. The uptake
of the other endogenous fatty acids in the perfusate was also
inhibited by these two omega-3 fatty acids (data not shown).
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Table II Effects of oleic, arachidonic, a-linolenic and eicosapentaenoic acids on
linoleic acid uptake and the stimulation of 3H-thymidine incorporation by linoleic acid
in hepatoma 7288CTC perfused in situ
Tumour
Plasma Tumour fatty 3H-thymidine
concentration acid uptake incorporation
Fatty acids added mM nmolg 'min-' dp.m. lg' DNA
Linoleic acid 0.50 10.8 0.9 342± 8
Arachidonic acid 0.47 3.3 ± 0.7 122 ± 12
Linoleic acid 0.64 11.1 ± 0.09
+ 361±2
Oleic acid 0.99 1.9 ± 0.6
Linoleic acid 0.47 5.8 ± 0.6
+ 459± 16a
Arachidonic acid 0.47 8.3 ± 1.3
Linoleic acid 0.57 2.6 ± 0.9
+ 127 7a
a-Linolenic acid 0.59 0.4 0.2
Linoleic acid 0.52 2.3 ± 0.2
+ 135±6a
Eicosapentaenoic acid 0.36 2.7 ± 0.4
Values are means ± SD for three experiments. aThese values are different (P <0.05)
from the mean value obtained in the presence of linoleic acid alone.
a
0) 1.2
12
a'I
-a70.8
0.4 0.8 4Concentration, mM
c
0
0.
0)
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Plasma omega-3 fatty acid concentration, mm
Figure 2 Effects of alpha-linolenic and eicosapentaenoic acids on the rates of linoleic acid utilisation a, and linoleic acid-dependent
3H-thymidine incorporation b, by hepatoma 7288CTC. Hepatomas 7288CTC were perfused for 2 h in situ with donor blood
containing added linoleic acid (0.5 mM) and 0, 0.05, 0.12, 0.28, 0.59, or 0.94 mm alpha-linolenic (0) acid or 0, 0.1 or 0.36 mM
eicosapentaenoic (0) acid. Each point represents mean ± s.d. for perfusions performed on three different tumours. The insets are
plots of reciprocal rates against the omega-3 fatty acid concentrations.
Discussion
The purpose of this study was to determine the effects of
omega-6 and omega-3 free fatty acids on 3H-thymidine incor-
poration in tissue-isolated hepatomas 7288CTC perfused in
situ. This tumour model replicates the in vivo condition and
removes the tumour from host effects that cannot be con-
trolled; we hoped these experiments would aid understanding
of how these fatty acids affect tumour growth. Choices were
made in the selection of the nutritional state of the animals
and in methods of preparing the whole blood perfusate and
should be discussed.
EFA-deficient animals were used for tumour growth and
as sources of donor blood. In previous experiments (Sauer &
Dauchy, 1988), we used rats fed normal laboratory chow for
these purposes. The tumours contained large amounts of
linoleic and arachidonic acids and the linoleic and arachi-
donic acid concentrations in donor blood plasma ranged
from less than 0.1 to greater than 0.3 mM, depending on the
feeding activity of the host rats (Sauer & Dauchy, 1992).
Baseline rates of 3H-thymidine incorporation in tumours per-
fused with this blood were about 100 d.p.m. Lg-' DNA and
were increased to about 160 d.p.m. pg-' DNA by 0.7 mM
plasma linoleic acid. It seemed likely that these baseline rates
could be further decreased if the tumours were grown in
EFA-deficient rats and were perfused with donor blood from
other EFA-deficient rats. The response of the tumour to
exogenous linoleate might also be increased. These expecta-
tions were observed; baseline levels of 3H-thymidine incor-
poration were decreased to about 40 d.p.m. sg-' DNA and
the Vmax response of the perfused tumour to 0.7 mm plasma
linoleate was increased to about 350 d.p.m. .tg-' DNA.
Clearly, EFA-deficiency influences the metabolism of both
the host and tumour: host animals were very susceptible to
water loss and dehydration and tumours implanted in these
animals grow more slowly (Hillyard & Abraham, 1979; Sauer
& Dauchy, 1990). Despite the slower tumour growth, the
important reactions in this study, fatty acid uptake and
utilisation and tumour 3H-thymidine incorporation, remained
intact. Most important were the qualitatively identical res-
ponses in 3H-thymidine incorporation of tumours growing in
EFA-sufficient rats (Sauer & Dauchy, 1988) and EFA-
deficient rats (Table III and Figure 1) during perfusion with
increased concentrations of linoleic or arachidonic acids. The
larger, more significant level of 3H-thymidine incorporation
was observed in tumours growing in EFA-deficient rats.
Because tumours grown in EFA-deficient rats have low
endogenous levels of essential fatty acids and respond briskly
to exogenous linoleic acid, we believe this host-tumour model
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will be useful in experiments designed to determine mechan-
isms of action.
It is important to note that the EFA-deficient rats were fed
a diet that contained 20% protein, 0.3% methionine, 65%
carbohydrate, and 5% fat, plus vitamins, minerals, and
choline bitartrate equivalent to that in normal rat chow.
Blood FFA and lipoproteins from these animals contained
saturated, monounsaturated and eicosa-5,8,11-trienoic acids.
Only the essential fatty acids and their metabolites were low
or absent. Body growth was slower than that of animals fed
an EFA-sufficient diet, and it continued throughout the life
of the rats. Also, EFA-deficient animals accumulated fat
stores indicating that the energy supply was adequate. Pooled
donor blood removed from EFA-deficient rats (used for per-
fusion) was identical in nutrient content to blood in the host
rat and had no effect on baseline tumour3H-thymidine incor-
poration. Rather, the stimulative effect was observed only in
tumours perfused with donor blood containing linoleic,
gamma-linolenic, dihomo-gamma-linolenic or arachidonic
acid. It seems very unlikely, therefore, that the stimulative
effects on tumour 3H-thymidine incorporation illustrated in
Figure la were caused by an endogenous factor in the pooled
blood from EFA-deficient rats. In agreement with this reason-
ing, we showed that tumour growth in EFA-deficient rats was
specifically increased by exogenous linoleic acid (Sauer &
Dauchy, 1990).
FFA metabolism in perfused organs, such as liver, is most
often studied using perfusates formed by adding a FFA-
bovine serum albumin complex to whole blood or to
buffered-erythrocyte suspensions (Nestel & Steinberg, 1963;
Van Harken et al., 1969; Soler-Argilaga et al., 1974). Addi-
tion of FFA-albumin complexes dilutes the original plasma
and may add unwanted proteins and peptides to the per-
fusate. Although there was no evidence that FFA uptake
from a rat plasma-bovine albumin-FFA mixture would not
occur or would be different from normal rat plasma, we
decided to avoid the effect of dilution and the presence of
foreign proteins. Initial attempts to add FFA directly to rat
plasma using a solid resin procedure (Spector & Hoak, 1969)
were not completely successful because, in our hands, FFA
transfer from celite to albumin was variable and the plasma
FFA concentration needed to be measured before the per-
fusion was performed. The perfusates used in these
experiments were prepared by adding purified FFAs (as
sodium salts) directly to the donor blood plasma. The cel-
lular fraction was then added back to reconstitute the whole
blood. This procedure was quick, the transfer of FFA to rat
plasma albumin was stoichiometric, no other potentially
harmful proteins or peptides were added, and the FFA did
not redistribute to other plasma lipids in either the arterial
blood perfusate or the tumour venous blood. Most impor-
tantly, tumour supply and uptake of the exogenous FFA
were not detectably different from that of endogenous FFAs.
The mechanisms by which plasma free linoleic and arachi-
donic acids increase 3H-thymidine incorporation in tumours
perfused in situ have yet to be determined. The data reported
here suggest that these fatty acids may act differently. Mole
for mole, linoleic acid consistently had a greater stimulative
effect than did arachidonic acid. This difference is seen in the
dose-response relationships illustrated in Figure 1. The Vmax
for tumour 3H-thymidine incorporation during perfusion with
linoleate was about three times greater than that with
arachidonate. Also, the reactions due to each fatty acid were
saturable. Experiments in which linoleic and arachidonic acids
were combined in the perfusate (Table III, and see Sauer &
Dauchy, 1988) suggested that the effects of the two acids
were additive. Therefore, it seems very unlikely that linoleate
and arachidonate act through a single, common reaction.
Both linoleic and arachidonic acids are substrates for fur-
ther enzyme oxidations in cells. Conceivably, these fatty acids
(or their metabolites) acting independently of each other
increase the rate of DNA synthesis of tumour cells in active S
phase. Alternatively, these fatty acids could act to recruit new
cells into S phase and/or to activate cells arrested in S phase.
Each of these actions would be measured as an increase in
the rate of3H-thymidine incorporation and ultimately as an
increase in tumour DNA content. However, during the 2 h
perfusion no increase in tumour DNA content was observed,
even in those tumours showing the highest rates of 3H-
thymidine incorporation (see also Sauer & Dauchy, 1988).
Presumably, not enough new DNA was formed to be de-
tected chemically. Since perfusions longer than 2 h are
difficult to complete successfully, the question of amounts of
new DNA synthesised must be examined using more sensitive
analytical methods.
Finally, a plausible and non-trivial explanation would
result if either linoleate or arachidonate (or both) acted to
decrease the thymidine pool size in the tumour cells. Such a
change could increase the effective specific activity of the
administered 3H-thymidine dose and increase the amount of
3H-thymidine incorporated without changing the tumour
DNA content. In our opinion, mechanisms based on changes
in intracellular thymidine pools are the least satisfactory
because (1) two different thymidine pool size regulatory reac-
tions would appear to be required to explain the different
stimulative effects of linoleic and arachidonic acids (Figure 1)
and (2) the decreases in pool sizes would need to be additive
(Table III). Also, it is difficult to envisage how decreases in a
thymidine pool could be responsible for the increased tumour
growth and DNA content associated with longer exposures
to high plasma free linoleic and arachidonic acid concentra-
tions (Sauer et al., 1986; Sauer & Dauchy, 1987). Unfor-
tunately, analyses of precursor pools are difficult to interpret
especially in solid tumours composed of several different cell
types; determination of an average nucleotide pool has no
biochemical meaning in a solid tumour. We believe the simp-
lest, most testable explanation for these data is that ambient
concentrations of plasma free linoleic and arachidonic acids
act positively via concentration dependent reactions to in-
crease the rate of DNA synthesis in tumours cells that are in
S phase. Clearly, these early events in linoleate- and arachi-
donate-stimulated tumour 3H-thymidine incorporation are
imperfectly understood and require further experimentation.
It is of interest to compare the specificity of fatty acid
requirements in: tumour growth in vivo (see Welsch, 1987 for
a review); 3H-thymidine incorporation in tumours perfused in
situ; and 3H-thymidine incorporation and growth in cancer
cells in culture. Similarities and differences discovered using
these three different systems are pertinent. Despite early
reports that high fat diets increased tumour growth, evidence
now points to dietary linoleic acid intake as the critical factor
(Hillyard & Abraham, 1979; Ip et al., 1985). Ingested
arachidonic acid had no effect (Hillyard & Abraham, 1979).
In solid tumours perfused in situ, linoleic acid caused a large
response in 3H-thymidine incorporation; arachidonic, gam-
ma-linolenic and dihomo-gamma linolenic acids were also
active, albeit at about one-third the activity of linoleic acid
(Sauer & Dauchy, 1988; and see Figure 1 and Table II).
Perfusion with saturated or monounsaturated fatty acids had
no effect (Sauer & Dauchy, 1988). Rodent and human
tumour cells in culture show increased rates of cell prolifera-
tion (Holley et al., 1974; Wicha et al., 1979; Rose & Connelly,
1990) and increased rates of 3H-thymidine incorporation
(Wicha et al., 1979; Rose & Connelly, 1990) when linoleic,
arachidonic or oleic acid was included in the medium. Thus,
the fatty acid requirement for growth of tumours in vivo, for
3H-thymidine incorporation in tissue-isolated perfused tu-
mours, or for 3H-thymidine incorporation and growth of
tumour cells in culture is characterised by a progressive
decrease in fatty acid specificity. Studies of mechanism
require models that duplicate the intact animal; we believe
that the tissue-isolated tumour perfused in situ serves this
purpose best.
The mechanism of action of the omega-3 fatty acids is also
not known. Ingestion of these fatty acids has an inhibitory
effect on tumour growth in vivo (Karmali et al., 1984; Gabor
& Abraham, 1986) and, when omega-3 fatty acids were
ingested with linoleic acid, the positive growth effects of
linoleic acid were decreased (Gabor & Abraham, 1986).
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eicosapentaenoic acids inhibited both linoleic acid uptake
and the stimulative effect of linoleate on tumour 3H-thy-
midine incorporation (Table III and Figure 2). Assuming
that inhibition of 3H-thymidine incorporation in a tumour
perfused in situ and inhibition of growth of a tumour mass in
the intact rat are the first and the final stages of the same
inhibitory process, one could expect similar mechanisms. In
support of this reasoning, it is known that feeding diets
containing omega-3 fatty acids either alone or in combina-
tion with linoleic acid caused a substantial decrease in the
tumour content of linoleic acid (Gabor & Abraham, 1986),
suggesting a decrease in uptake. It seems likely, therefore,
that ingestion of dietary oils containing omega-3 fatty acids
increased the ambient levels of plasma free omega-3 fatty
acids in host arterial blood and this increase competively
inhibited tumour linoleate uptake. Since linoleic acid uptake
appears to be critical for determining the tumour growth
rate, the result is an omega-3 fatty acid-mediated decrease in
tumour growth. Further experiments designed to test this
hypothesis are in progress.
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